We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01571206
Recruitment Status : Completed
First Posted : April 5, 2012
Last Update Posted : July 31, 2013
Information provided by (Responsible Party):